[Therapy of hypertrophic cardiomyopathy].
Cecchi
F
F
Azienda Ospedaliera di Careggi, Firenze.
Olivotto
I
I
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D004232:Diuretics / Q000627:therapeutic use; D018618:Echocardiography, Doppler, Color; D004554:Electric Countershock; D004562:Electrocardiography; D006333:Heart Failure / Q000628:therapy; D006439:Hemodynamics; D006801:Humans; D011379:Prognosis; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D004232:Diuretics